Upgrade of ductal carcinoma in situ on core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme.

[1]  J. Connolly,et al.  Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. , 1989, Radiology.

[2]  L. Tabár,et al.  The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.

[3]  Julie Cooke,et al.  CLINICAL GUIDELINES FOR BREAST CANCER SCREENING ASSESSMENT , 2001 .

[4]  I. Ellis,et al.  Predicting invasion in mammographically detected microcalcification. , 2001, Clinical radiology.

[5]  W. P. Evans,et al.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. , 2001, Radiology.

[6]  Kornelia Polyak,et al.  Ductal Carcinoma in Situ of the Breast , 2004, Strahlentherapie und Onkologie.

[7]  D. Evans,et al.  Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy. , 2009, Clinical radiology.

[8]  E. Kurniawan,et al.  Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. , 2010, Archives of surgery.

[9]  S. Ciatto,et al.  Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. , 2011, Radiology.

[10]  A. Luini,et al.  Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. , 2012, Breast.

[11]  H. Moon,et al.  Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy. , 2012, The British journal of radiology.

[12]  M. Golatta,et al.  Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. , 2013, Breast.